Literature DB >> 2539181

Immunohistochemical localisation of tissue plasminogen activator in human brain tumours.

A J Franks1, E Ellis.   

Abstract

The distribution of tissue plasminogen activator (t-PA) has been studied in a series of 38 human brain tumours and two specimens of cerebral cortex, using the monoclonal antibody ESP6. t-PA was localised in vascular endothelium in the majority of tumours and both the cortical specimens, confirmed by double staining with Ulex europaeus lectin (Uel) and Factor 8-related antigen. Nineteen out of 22 high grade astrocytomas showed strong endothelial staining whereas staining was weak or absent in the four low grade astrocytomas studied. No consistent relationship was found between the pattern of staining and tumour grade in the other tumours, although strong staining of the three metastatic lesions with Uel was observed. Among the astroglial tumours only one glioblastoma showed any tumour cell staining for t-PA, which raises questions concerning the origin of t-PA producing cells derived from human gliomas in vitro. Studies of t-PA in brain tumours should take account of this vascular localisation before concluding that the activity is derived from neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539181      PMCID: PMC2247065          DOI: 10.1038/bjc.1989.95

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors.

Authors:  F Cohadon; N Aouad; A Rougier; C Vital; J Rivel; J F Dartigues
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

2.  Antigenic expression by cells derived from human gliomas does not correlate with morphological classification.

Authors:  P G Kennedy; B A Watkins; D G Thomas; M D Noble
Journal:  Neuropathol Appl Neurobiol       Date:  1987 Sep-Oct       Impact factor: 8.090

3.  Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration.

Authors:  M Presta; D Moscatelli; J Joseph-Silverstein; D B Rifkin
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

4.  In vitro heterogeneity in human gliomas. Are all transformed cells of glial origin?

Authors:  A J Franks; H M Burrow
Journal:  Anticancer Res       Date:  1986 Jul-Aug       Impact factor: 2.480

5.  Correlation of tumor plasminogen activator with peritumoral cerebral edema. A CT and biochemical study.

Authors:  E A Quindlen; A P Bucher
Journal:  J Neurosurg       Date:  1987-05       Impact factor: 5.115

6.  Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas.

Authors:  P E McKeever; B H Smith; J A Taren; R L Wahl; P L Kornblith; B M Chronwall
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

7.  Helix pomatia and Ulex europeus lectin binding in human breast carcinoma.

Authors:  S Fenlon; I O Ellis; J Bell; J H Todd; C W Elston; R W Blamey
Journal:  J Pathol       Date:  1987-07       Impact factor: 7.996

8.  Four permanent cell lines established from human malignant gliomas: three exhibiting striated muscle differentiation.

Authors:  P F Jacobsen; D J Jenkyn; J M Papadimitriou
Journal:  J Neuropathol Exp Neurol       Date:  1987-07       Impact factor: 3.685

9.  Phenotypic modification of human glioma and non-small cell lung carcinoma by glucocorticoids and other agents.

Authors:  J S McLean; M C Frame; R I Freshney; P F Vaughan; A E Mackie; I Singer
Journal:  Anticancer Res       Date:  1986 Sep-Oct       Impact factor: 2.480

10.  Secretion of plasminogen activator by stimulated macrophages.

Authors:  J C Unkeless; S Gordon; E Reich
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

View more
  5 in total

Review 1.  The hemostatic system and angiogenesis in malignancy.

Authors:  M Z Wojtukiewicz; E Sierko; P Klement; J Rak
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

2.  Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells.

Authors:  Takuya Akai; Kenji Niiya; Nobuo Sakuragawa; Hideaki Iizuka; Shunro Endo
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

3.  Prognostic role of urokinase-type plasminogen activator in human gliomas.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

Review 4.  Prognostic significance of proteolytic enzymes in human brain tumors.

Authors:  A K Bindal; M Hammoud; W M Shi; S Z Wu; R Sawaya; J S Rao
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Inhibition of tumor necrosis factor-alpha and -beta secretion by lymphokine activated killer cells by transforming growth factor-beta.

Authors:  H Naganuma; A Sasaki; E Satoh; M Nagasaka; S Nakano; S Isoe; K Tasaka; H Nukui
Journal:  Jpn J Cancer Res       Date:  1994-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.